Skip to main content

Advertisement

SpringerLink
Log in

Autoimmunity in chronic urticaria and urticarial vasculitis

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

In contrast to acute urticaria, etiology cannot be identified in most cases of chronic urticaria. Recent evidence suggests that a subset of patients with chronic urticaria may have an autoimmune basis for their condition. The demonstration of antithyroid autoantibodies in some patients with chronic idiopathic urticaria (CIU) provides support for an association. However, the discovery of a positive skin test response to intradermal injection of autologous serum in as many as 60% of patients with CIU led to the identification of autoantibodies to IgE and the a-chain of the high-affinity IgE receptor, FceRIa. Additional studies have demonstrated that some of these autoantibodies are capable of releasing histamine from donor basophils and mast cells. This article reviews the literature that addresses a possible autoimmune etiology in a subset of patients with CIU. Urticarial vasculitis is differentiated from chronic urticaria based on clinical features and biopsy findings of leukocytoclastic vasculitis. Most cases of urticarial vasculitis are secondary to an underlying systemic disease. The presence of autoantibodies has also been demonstrated in a subset of patients with primary urticarial vasculitis. This article briefly reviews some of this data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Soter NA: Urticaria and angioedema. In Fitzpatrick’s Dermatology in General Medicine edn 5. Edited by Freedberg IM, Eisen A, Wolff K, et al. New York: McGraw-Hill; 1999:1409–1419.

    Google Scholar 

  2. Hall PA, Lemoine NR: Koch’s postulates revisited. J Pathol 1991, 164:283–284.

    Article  PubMed  CAS  Google Scholar 

  3. Witebsky E, Rose NR, Terplan K, et al.: Chronic thyroiditis and autoimmunization. JAMA 1957, 164:1439–1447.

    CAS  Google Scholar 

  4. Rose NR, Bona C: Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 1993, 14:426–430.

    Article  PubMed  CAS  Google Scholar 

  5. Hewins P, Tervaert JWC, Savage COS, Kallenberg CGM: Is Wegener’s granulomatosis an autoimmune disease? Rheumatology 2000, 12:3–10.

    CAS  Google Scholar 

  6. Isaacs NJ, Ertel NH: Urticaria and pruritus: uncommon manifestations of hyperthyroidism. J Allergy Clin Immunol 1971, 48:73–81.

    Article  PubMed  CAS  Google Scholar 

  7. Leznoff A, Josse RG, Denburg J, Dolovich J: Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983, 119:636–640.

    Article  PubMed  CAS  Google Scholar 

  8. Lanigan SW, Short P, Moult P: The association of chronic urticaria and thyroid autoimmunity. Clin Exp Dermatol 1987, 12:335–338.

    Article  PubMed  CAS  Google Scholar 

  9. Leznoff A, Sussman GL: Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989, 84:66–71.

    Article  PubMed  CAS  Google Scholar 

  10. Turktas I, Gokcora N, Demirsoy S, et al.: The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol 1997, 36:187–190.

    Article  PubMed  CAS  Google Scholar 

  11. Rumbyrt JS, Katz JL, Schocket AL: Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995, 96:901–905.

    Article  PubMed  CAS  Google Scholar 

  12. Peltz S, Barchuk W, Oppenheimer J, et al.: Chronic angioedema of the tongue associated with pernicious anemia and Hashimoto’s thyroiditis. Clin Exp Dermatol 1995, 20:351–352.

    Article  PubMed  CAS  Google Scholar 

  13. Koh CK, Hew FL, Chiu CL: Treatment of chronic urticaria with thyroxine in an euthyroid patient with thyroglobulin and microsomal antibodies. Ann Acad Med Singapore 2000, 29:528–530.

    PubMed  CAS  Google Scholar 

  14. Grattan CEH, Wallington TB, Warin RP, et al.: A serological mediator in chronic idiopathic urticaria- a clinical, immunological and histological evaluation. Br J Dermatol 1986, 114:583–590.

    Article  PubMed  CAS  Google Scholar 

  15. Gruber BL, Baeza ML, Marchese MJ, et al.: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988, 90:213–217.

    Article  PubMed  CAS  Google Scholar 

  16. Grattan CEH, Francis DM, Hide M, Greaves MW: Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991, 21:695–704.

    Article  PubMed  CAS  Google Scholar 

  17. Hide M, Francis DM, Grattan CEH, et al.: Autoantibodies against the high-affinity ige receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599–1604.

    Article  PubMed  CAS  Google Scholar 

  18. Fiebiger E, Maurer D, Holub H, et al.: Serum IgG autoantibodies directed against the a chain of FceRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest 1995, 96:2606–2612.

    Article  PubMed  CAS  Google Scholar 

  19. Niimi N, Francis DM, Kermani F, et al.: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996, 106:1001–1006.

    Article  PubMed  CAS  Google Scholar 

  20. Ferrer M, Kinet JP, Kaplan A: Comparative studies of functional and binding assays for IgG anti-FceRIa (a-subunit) in chronic urticaria. J Allergy Clin Immunol 1998, 101:672–676. This comparative study used sera from 68 patients with CIU to release histamine from donor basophils and dispersed human mast cells, demonstrating a significant correlation between the two different assays.

    Article  PubMed  CAS  Google Scholar 

  21. Tong LJ, Balakrishnan G, Kochan JP, et al.: Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997, 99:461–465.

    Article  PubMed  CAS  Google Scholar 

  22. Fiebiger E, Hammerschmid F, Stingl G, Maurer D: Anti-FceRIa autoantibodies in autoimmune-mediated disorders. J Clin Invest 1998, 101:243–251. Patients with CIU and other autoimmune diseases were evaluated for the presence of anti-FceRIa using an ELISA-based assay. Although these autoantibodies can be found in other autoimmune diseases, only sera from patients with CIU and anti-FceRIa autoantibodies released histamine. The IgG subtype of the anti-FceRIa autoantibodies in CIU was further characterized as IgG1 and IgG3, and the authors present data suggesting a role for complement.

    PubMed  CAS  Google Scholar 

  23. Ferrer M, Nakazawa K, Kaplan A: Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999, 104:169–172. The role for complement was investigated using histamine release from dispersed mast cells in response to untreated sera, heated sera (decomplemented), or isolated IgG from sera of patients with CIU. Only sera of patients with CIU or isolated IgG of patients with CIU combined with normal serum were able to release significantly more histamine than the control.

    Article  PubMed  CAS  Google Scholar 

  24. Horn MP, Gerster T, Ochensberger B, et al.: Human anti-FceRIa autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999, 29:1139–1148. Two different commercial multidonor IgG preparations were examined for anti-FceRIa autoantibodies. The autoantibodies were present and cross-reacted with tetanus toxoid but did not release histamine from donor basophils.

    Article  PubMed  CAS  Google Scholar 

  25. Fagiolo U, Kricek F, Ruf C, et al.: Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000, 106:567–572. Using sera from 15 patients with CIU and a positive ASST, it was demonstrated that 1) 14 sera had anti-FceRIa autoantibodies, 2) only sera from two patients released histamine from donor basophils, and 3) the ASST in these patients was unaffected by heat-treated/IgG-depleted sera. This study suggests that a positive ASST may be due to other HRFs present in the sera of CIU patients.

    Article  PubMed  CAS  Google Scholar 

  26. Grattan CEH, Boon AP, Eady RAJ, Winkelmann RK: The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990, 93:198–204.

    PubMed  CAS  Google Scholar 

  27. Sabroe RA, Grattan CEH, Francis DM, et al.: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446–452. The sensitivity and specificity of different parameters of the positive ASST were calculated for use in identifying patients with autoantibodies.

    Article  PubMed  CAS  Google Scholar 

  28. Wedi B, Novacovic V, Koerner M, Kapp A: Chronic urticaria serum induces histamine release, leukotriene production, basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000, 105:552–560. This article compared the sera from patients with CIU and a positive ASST, from patients with CIU and a negative ASST, and from atopic and nonatopic control subjects for its ability to release histamine using atopic and nonatopic donor cells. Additionally, basophil activation using surface expression of CD63 and leukotriene production was examined.

    Article  PubMed  CAS  Google Scholar 

  29. Grattan CEH, Francis DM, Slater NGP, et al.: Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992, 339:1078–1080.

    Article  PubMed  CAS  Google Scholar 

  30. Grattan CEH, Walpole D, Francis DM, et al.: Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997, 27:1417–1424.

    PubMed  CAS  Google Scholar 

  31. O’Donnell BF, Barr RM, Black AK, et al.: Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998, 138:101–106. Three of 10 patients with severe CIU were successfully treated using IVIg. Treatment options are offered.

    Article  PubMed  CAS  Google Scholar 

  32. Kroiss M, Vogt T, Landthaler M, Stolz W: The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria. Acta Derm Venereol 2000, 80:225.

    Article  PubMed  CAS  Google Scholar 

  33. Toubi E, Blant A, Kessel A, Golan TD: Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997, 52:312–316.

    Article  PubMed  CAS  Google Scholar 

  34. Grattan CEH, O’Donnell BF, Francis DM, et al.: Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol 2000, 143:365–372. In this initially double-blind study, cyclosporin was used to treat patients with CIU. Eight of 19 patients initially responded to 4 weeks of therapy, but six of the eight relapsed when therapy was discontinued. Only one was still clear at 6 months. All nonresponders and placebo patients were offered open-label cyclosporin. Eleven of 17 responded, with four remaining clear/almost clear at 6 months. Treatment options are offered in this article.

    Article  PubMed  CAS  Google Scholar 

  35. Black AK: Urticarial vasculitis. Clin Dermatol 1999, 17:565–569.

    Article  PubMed  CAS  Google Scholar 

  36. Wisnieski JJ: Urticarial vasculitis. Curr Opin Rheumatol 2000, 12:24–31. This is a good overall review of UV.

    Article  PubMed  CAS  Google Scholar 

  37. Freeman T: Cutaneous vasculitis. In Cutaneous Allergy. Edited by Charlesworth EN. Malden: Blackwell Science; 1996:313–329.

    Google Scholar 

  38. Zuberbier T, Henz BM, Fiebiger E, et al.: Anti- FceRIa serum autoantibodies in different subtypes of urticaria. Allergy 2000, 55:951–954. This is another study demonstrating the presence of anti-FceRIa autoantibodies in CIU.

    Article  PubMed  CAS  Google Scholar 

  39. Wisnieski JJ, Naff GB: Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 1989, 32:1119–1127.

    Article  PubMed  CAS  Google Scholar 

  40. Mehregan DR, Hall MJ, Gibson LE: Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992, 26:441–448.

    Article  PubMed  CAS  Google Scholar 

  41. Wisnieski JJ, Baer AN, Christensen J, et al.: Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients. Medicine 1995, 74:24–41.

    Article  PubMed  CAS  Google Scholar 

  42. O’Donnell BF, O’Neill CM, Francis DM, et al.: Human leukocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999, 140:853–858.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Allergy/Immunology, Wilford Hall Medical Center, Lackland Air Force Base, 78236, San Antonio, TX, USA

    Diane C. Napoli MD & Theodore M. Freeman MD

Authors
  1. Diane C. Napoli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore M. Freeman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Napoli, D.C., Freeman, T.M. Autoimmunity in chronic urticaria and urticarial vasculitis. Curr Allergy Asthma Rep 1, 329–336 (2001). https://doi.org/10.1007/s11882-001-0044-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-001-0044-0

Keywords

Search

Navigation